CSN Login
Members Online: 3

FDA Issues Alert on Genentech's Avastin

Posts: 33
Joined: May 2008

The FDA issued an alert about Genentech's cancer drug Avastin, saying the drug has been tied to the development of anemia in several patients, Dow Jones reports. Several patients who took Avastin in combination with the cancer drug Sutent reported microangiopathic hemolytic anemia, which is characterized by a loss of red blood cells, according to an alert posted on the FDA's Web site. (Dow Jones)

Subscribe with RSS
About Cancer Society

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2015 © Cancer Survivors Network